Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Feb 26;13(2):e232741.
doi: 10.1136/bcr-2019-232741.

Unexpected combination: DiGeorge syndrome and myeloperoxidase deficiency

Affiliations
Case Reports

Unexpected combination: DiGeorge syndrome and myeloperoxidase deficiency

Simona Abraitytė et al. BMJ Case Rep. .

Abstract

We report a case of a 3-year-old boy who presented with recurrent bacterial and fungal infections and a known diagnosis of partial DiGeorge (22q11.2 deletion) syndrome. The nature and severity of his infections were more than normally expected in partial DiGeorge syndrome with normal T-cell counts and T-cell proliferative response to phytohaemagglutinin. This prompted further investigation of the immune system. An abnormal neutrophil respiratory oxidative burst, but normal protein expression of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase system, led to the identification of myeloperoxidase deficiency. DiGeorge syndrome has a heterogeneous clinical phenotype and may not be an isolated diagnosis. It raises awareness of the possibility of two rare diseases occurring in a single patient and emphasises that even when a rare diagnosis is confirmed, if the clinical features remain atypical or unresponsive, then further investigation for additional cofactors is warranted.

Keywords: genetic screening/counselling; immunology; infections; paediatrics (drugs and medicines).

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. McDonald-McGinn DM, Sullivan KE, Marino B, et al. . 22Q11.2 deletion syndrome. Nat Rev Dis Primers 2015;1:1–46. 10.1038/nrdp.2015.71 - DOI - PMC - PubMed
    1. Klebanoff SJ, Kettle AJ, Rosen H, et al. . Myeloperoxidase: a front-line Defender against phagocytosed microorganisms. J Leukoc Biol 2013;93:185–98. 10.1189/jlb.0712349 - DOI - PMC - PubMed
    1. Pahwa R, Jialal I. Myeloperoxidase Deficiency. 2019Jun 4.StatPearls [Internet. Treasure Island (FL: StatPearls Publishing, 2019. - PubMed
    1. Suksawat Y, Sathienkijkanchai A, Veskitkul J, et al. . Resolution of primary immune defect in 22q11.2 deletion syndrome. J Clin Immunol 2017;37:375–82. 10.1007/s10875-017-0394-6 - DOI - PubMed
    1. Kwan A, Abraham RS, Currier R, et al. . Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 2014;312:729–38. 10.1001/jama.2014.9132 - DOI - PMC - PubMed

Publication types

Supplementary concepts